SUBSCRIBE
SUBSCRIBE

Texas

LATEST FROM BIOSPACE
Business
Eli Lilly Sales Rep and Son Die in Texas Flooding
June 3, 2015
 · 
1 min read
Lone Star Bio
University of Houston Researchers Identify Less-Invasive Method For Kidney Diagnostics
June 3, 2015
 · 
3 min read
Lone Star Bio
Suppressing Guilty Memories Reduces Their Impact On Unconscious Behavior, University of Texas Study
June 3, 2015
 · 
1 min read
Radius Health Plans to Double Staff in 2015, Exec Tells BioSpace
Biotech Beach
Radius Health Plans to Double Staff in 2015, Exec Tells BioSpace
June 2, 2015
 · 
3 min read
Astellas Pharma, Proteostasis Therapeutics Forge $1.2 Billion Genetic Disease Drug Development Pact
Business
EXCLUSIVE: Nektar Therapeutics, University of Texas MD Anderson Cancer Center Team Up on Phase 1/2 Trial of NKTR-214
June 2, 2015
 · 
5 min read
Biotech Bay
BioSpace Temperature Poll: Will PfizerKline Become the Next Pharma Player?
May 27, 2015
 · 
1 min read
Lone Star Bio
Botox Seems To Ease Depression, University Of Texas Medical Center Reveals
May 21, 2015
 · 
1 min read
Lone Star Bio
Drinking Coffee May Lower Erectile Dysfunction Risk, University of Texas Health Science Center Study
May 20, 2015
 · 
1 min read
BioMidwest
BioSpace Temperature Poll: Will Mylan Buy Teva, As Predator Becomes Prey?
May 19, 2015
 · 
1 min read
HR Exec Says Alder BioPharmaceuticals Will Grow 30% in 2015, As Hunt for Candidates Continues
BioMidwest
HR Exec Says Alder Biopharma Will Grow 30% in 2015, As Hunt for Candidates Continues
May 12, 2015
 · 
3 min read
Load More
PRESS RELEASES
Press Releases
Natera and Eledon Announce Strategic Partnership for Prospera™ Monitoring in Planned Phase 3 Kidney Transplant Trial
June 25, 2026
 · 
8 min read
Press Releases
Plus Therapeutics Secures National Coverage Agreement with Elevance Health for CNSide® Cerebrospinal Fluid Assay for Metastatic CNS Cancer
June 25, 2026
 · 
3 min read
Press Releases
Taysha Gene Therapies Announces Pricing of Public Offering of Common Stock and Pre-Funded Warrants
June 25, 2026
 · 
5 min read
Press Releases
Ollin Biosciences Announces Oversubscribed $330 Million Series B Financing to Advance Global Phase 3 Development of OLN324 in DME and Wet AMD; Studies Commencing in Second Half of 2026
June 24, 2026
 · 
5 min read
Press Releases
Signatera™ Receives Regulatory Approval in Japan for Colorectal Cancer
June 24, 2026
 · 
5 min read
Press Releases
Susan G. Komen® Awards $15.4 Million In Research Grants to Accelerate Breakthroughs in Breast Cancer Care
June 24, 2026
 · 
6 min read
Press Releases
Alpha Cognition Announces Election of Dr. Robert Wills as Chairman of the Board
June 24, 2026
 · 
5 min read
Press Releases
Hope Biosciences Reports Positive Published Clinical Data Following Stem Cell Therapy in Chronic Traumatic Brain Injury
June 23, 2026
 · 
2 min read
Press Releases
NCCN Recommends ctDNA-MRD Testing Using Signatera™ Technology in Landmark Bladder Cancer Guideline Update
June 23, 2026
 · 
4 min read
Press Releases
Plus Therapeutics to Provide Business Update Call on June 30, 2026
June 23, 2026
 · 
4 min read
Load More